As has been mentioned above, increased SOCS2 expression in malignancies like CML [219, 220] could contribute to oncogenesis by negative control of other SOCSs functions that normally would suppress tumor development. Here, SOCS2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.